Clinical research has suggested that the levels of FOXO proteins in the central nervous system may be altered in research models of neurodegenerative disorders (NDDs)
It prompts the pancreas to release insulin when blood sugar is high, suppresses glucagon, and slows digestion actions that work together to lower blood sugar while reducing the risk of hypoglycemia
Materials and methods Antibodies and reagents PC2 antibody (D1E1S), t-PKA antibody (D38C6), p-PKA antibody (D45D3), Pdx1 antibody (D59H3), GLP-1R antibody (HA500204) and all secondary antibodies used in Western blot were purchased from Cell Signaling Technology (Beverly, MA, United States)
Biomed Pharmacother 2019, 110: 420430
Kidney Int 66(4):16131621 Ogawa T, Kimono M, Sasaoka K (1989) Purification and properties of a new enzyme, NG-dimethylargininedimethylaminohydrolase, from rat kidney